Related Experiment Video
Updated: Sep 25, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Adaptive antimicrobial resistance, a description of microbial variants, and their relevance to periprosthetic joint
Christopher Hamad1, Madhav Chowdhry2, Devin Sindeldecker3,4
1Department of Orthopaedic Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
Abstract:
Periprosthetic joint infection (PJI) is a difficult complication requiring a comprehensive eradication protocol. Cure rates have essentially stalled in the last two decades, using methods of antimicrobial cement joint spacers and parenteral antimicrobial agents. Functional spacers with higher-dose antimicrobial-loaded cement and antimicrobial-loaded calcium sulphate beads have emphasized local antimicrobial delivery on the premise that high-dose local antimicrobial delivery will enhance eradication. However, with increasing antimicrobial pressures, microbiota have responded with adaptive mechanisms beyond traditional antimicrobial resistance genes. In this review we describe adaptive resistance mechanisms that are relevant to the treatment of PJI. Some mechanisms are well known, but others are new. The objective of this review is to inform clinicians of the known adaptive resistance mechanisms of microbes relevant to PJI. We also discuss the implications of these adaptive mechanisms in the future treatment of PJI. Cite this article: Bone Joint J 2022;104-B(5):575-580.
Insights
Periprosthetic joint infection (PJI) treatment is challenging due to evolving microbial adaptive resistance. Understanding these mechanisms is crucial for improving patient outcomes and developing new therapeutic strategies.
Area of Science:
- Orthopedics
- Infectious Diseases
- Microbiology
Background:
- Periprosthetic joint infection (PJI) presents a significant challenge in orthopedic surgery, with current treatment protocols showing stagnant cure rates.
- Established methods like antimicrobial cement spacers and parenteral antibiotics have limitations in eradicating PJI.
- Emerging adaptive microbial resistance mechanisms complicate treatment beyond traditional antimicrobial resistance.
Purpose of the Study:
- To review known and novel adaptive resistance mechanisms employed by microbes relevant to PJI.
- To inform clinicians about these adaptive mechanisms and their impact on PJI treatment.
- To discuss the implications of microbial adaptive resistance for future PJI therapeutic strategies.
Main Methods:
- Literature review focusing on adaptive resistance mechanisms in microbes associated with PJI.
- Analysis of current treatment strategies and their limitations in the context of evolving microbial adaptations.
- Synthesis of information on both well-documented and newly identified resistance mechanisms.
Main Results:
- Microbiota have developed adaptive resistance mechanisms in response to increased antimicrobial pressure, extending beyond conventional resistance genes.
- These adaptive mechanisms represent a significant hurdle in achieving successful PJI eradication.
- Both established and novel adaptive resistance strategies employed by microbes are detailed.
Conclusions:
- Understanding microbial adaptive resistance is essential for advancing PJI treatment protocols.
- Future strategies for PJI management must account for these sophisticated microbial defense mechanisms.
- This review provides critical insights for clinicians to navigate the complexities of PJI treatment in the face of evolving antimicrobial resistance.
More Related Videos
Related Concept Videos
Development of Antibiotic Resistance
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Endocarditis I: Introduction
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Endocarditis III: Medical Management
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

